Seguir
Fernando Eduardo Padovan-Neto, PhD
Fernando Eduardo Padovan-Neto, PhD
Pesquisador Colaborador, Departamento de Psicologia, FFCLRP-USP
E-mail confirmado em usp.br
Título
Citado por
Citado por
Ano
Role of nitric oxide on motor behavior
EAD Bel, FS Guimaraes, M Bermũdez-Echeverry, MZ Gomes, ...
Cellular and molecular neurobiology 25 (2), 371-392, 2005
1452005
Glial activation is associated with l-DOPA induced dyskinesia and blocked by a nitric oxide synthase inhibitor in a rat model of Parkinson's disease
M Bortolanza, R Cavalcanti-Kiwiatkoski, FE Padovan-Neto, CA da-Silva, ...
Neurobiology of disease 73, 377-387, 2015
1052015
Phosphodiesterase 10A Inhibition Improves Cortico-Basal Ganglia Function in Huntington’s Disease Models
V Beaumont, S Zhong, H Lin, WJ Xu, A Bradaia, E Steidl, M Gleyzes, ...
Neuron, 2016
1022016
Nitric oxide synthase inhibition attenuates L-DOPA-induced dyskinesias in a rodent model of Parkinson's disease
FE Padovan-Neto, MB Echeverry, V Tumas, EA Del-Bel
Neuroscience 159 (3), 927-935, 2009
982009
Effects of prolonged neuronal nitric oxide synthase inhibition on the development and expression of L-DOPA-induced dyskinesia in 6-OHDA-lesioned rats
FE Padovan-Neto, R Cavalcanti-Kiwiatkoviski, ROG Carolino, ...
Neuropharmacology, 2014
542014
Role of Nitric Oxide in Motor Control: Implications for Parkinsons Disease Pathophysiology and Treatment
E Del-Bel, F Eduardo Padovan-Neto, R Raisman-Vozari, M Lazzarini
Current pharmaceutical design 17 (5), 471-488, 2011
532011
Are cyclooxygenase-2 and nitric oxide involved in the dyskinesia of Parkinson's disease induced by l-DOPA?
M Bortolanza, FE Padovan-Neto, R Cavalcanti-Kiwiatkoski, ...
Phil. Trans. R. Soc. B 370 (1672), 20140190, 2015
522015
Nitric oxide synthase inhibitor improves de novo and long-term L-DOPA-induced dyskinesia in hemiparkinsonian rats
FE Padovan-Neto, MB Echeverry, S Chiavegatto, E Del-Bel
Frontiers in systems neuroscience 5, 2011
502011
Facilitation of corticostriatal transmission following pharmacological inhibition of striatal phosphodiesterase 10A: role of nitric oxide-soluble guanylyl cyclase-cGMP …
FE Padovan-Neto, S Sammut, S Chakroborty, AM Dec, S Threlfell, ...
The Journal of Neuroscience 35 (14), 5781-5791, 2015
482015
Anti-dyskinetic effect of the neuronal nitric oxide synthase inhibitor is linked to decrease of FosB/DeltaFosB expression
FE Padovan-Neto, NR Ferreira, D Tavares, D de Aguiar, CA Silva, ...
Neuroscience Letters, 2013
372013
Counteraction by Nitric Oxide Synthase Inhibitor of Neurochemical Alterations of Dopaminergic System in 6-OHDA-Lesioned Rats Under l-DOPA Treatment
E Del-Bel, FE Padovan-Neto, RE Szawka, CA da-Silva, ...
Neurotoxicity research, 1-12, 2013
332013
Investigations into Potential Extrasynaptic Communication between the Dopaminergic and Nitrergic Systems
M Mitkovski, FE Padovan-Neto, R Raisman-Vozari, L Ginestet, C Da-Silva, ...
Frontiers in Physiology 3, 372, 2012
332012
Nitric Oxide, a new player in L-DOPA-induced dyskinesia?
E Del-Bel, FE Padovan-Neto, M Bortolanza, V Tumas, JAS Aguiar, ...
Frontiers in bioscience (Elite edition) 7, 193-221, 2014
282014
Age-and sex-related changes in cortical and striatal nitric oxide synthase in the Q175 mouse model of Huntington's disease
FE Padovan-Neto, L Jurkowski, C Murray, GE Stutzmann, M Kwan, ...
Nitric Oxide 83, 40-50, 2019
232019
Lack of tolerance for the anti-dyskinetic effects of 7-nitroindazole, a neuronal nitric oxide synthase inhibitor, in rats
N Novaretti, FE Padovan-Neto, V Tumas, CA Da-Silva, EA Del Bel
Brazilian Journal of Medical and Biological Research 43 (11), 1047-1053, 2010
212010
Selective regulation of 5-HT1B serotonin receptor expression in the striatum by dopamine depletion and repeated L-DOPA treatment: Relationship to L-DOPA-induced dyskinesias
FE Padovan-Neto, S Patterson, NMF Voelkner, F Altwal, JA Beverley, ...
Molecular neurobiology 57 (2), 736-751, 2020
192020
Regulation of Striatal Neuron Activity by Cyclic Nucleotide Signaling and Phosphodiesterase Inhibition: Implications for the Treatment of Parkinson’s Disease
FE Padovan-Neto, AR West
Phosphodiesterases: CNS Functions and Diseases, 257-283, 2017
182017
Disturbance of sensorimotor filtering in the 6-OHDA rodent model of Parkinson's disease
AC Issy, FE Padovan-Neto, M Lazzarini, M Bortolanza, E Del-Bel
Life sciences 125, 71-78, 2015
182015
Neurotransmissão g ansmissão g ansmissão glutamatérgica e plasticidade sináptica: aspectos mo-leculares, clínicos ef línicos ef línicos e filogenéticos
RN Ruggiero, LS Bueno-Júnior, JB de Ross, HA Fachim, ...
Medicina (Ribeirão Preto) 44 (2), 143-56, 2011
17*2011
Repurposing an established drug: an emerging role for methylene blue in L‐DOPA‐induced dyskinesia
K Bariotto‐dos‐Santos, FE Padovan‐Neto, M Bortolanza, ...
European Journal of Neuroscience, 2018
142018
O sistema não pode executar a operação agora. Tente novamente mais tarde.
Artigos 1–20